Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors. Fujita N, Handa A, Park JM. Anticancer Res 2022;42:911-917.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fujita N, Handa A, Park JM. Peritumoral Hyperintensity at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI in Hepatic Neuroendocrine Tumors. Anticancer Res 2022;42:911-917.
PMID: 35093889